I C U Medical Inc
(ICUI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -117,688 | -29,655 | -74,286 | 103,135 | 86,870 |
| Depreciation Amortization | 226,319 | 235,588 | 268,642 | 90,593 | 86,150 |
| Accounts receivable | -46,844 | 48,635 | -19,151 | 13,755 | 78,049 |
| Accounts payable and accrued liabilities | 12,531 | -68,301 | 37,472 | 2,347 | -46,415 |
| Other Working Capital | -2,569 | -135,603 | -303,729 | 15,039 | -16,966 |
| Other Operating Activity | 132,284 | 115,537 | 28,923 | 42,669 | 35,064 |
| Operating Cash Flow | $204,033 | $166,201 | $-62,129 | $267,538 | $222,752 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | -3,250 | N/A |
| PPE Investments | -78,627 | -82,392 | -89,322 | -68,324 | -85,829 |
| Net Acquisitions | N/A | N/A | -1,844,164 | -14,452 | N/A |
| Purchase Of Investment | 0 | 0 | -3,397 | -10,034 | -32,825 |
| Sale Of Investment | 500 | 4,222 | 36,433 | 18,000 | 28,900 |
| Purchase Sale Intangibles | -10,833 | -9,777 | -9,018 | -12,627 | -8,385 |
| Other Investing Activity | -10,833 | -9,777 | -9,018 | -12,627 | -8,385 |
| Investing Cash Flow | $-88,960 | $-87,947 | $-1,909,468 | $-90,687 | $-98,139 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 150,000 |
| Debt Issued | N/A | N/A | 1,664,362 | N/A | N/A |
| Debt Repayment | -52,147 | -30,651 | -23,055 | -607 | -357 |
| Common Stock Issued | 10,939 | 4,022 | 8,785 | 9,372 | 13,193 |
| Other Financing Activity | -14,592 | -9,350 | -13,060 | -25,635 | -162,876 |
| Financing Cash Flow | $-55,800 | $-35,979 | $1,637,032 | $-16,870 | $-40 |
| Exchange Rate Effect | -4,929 | 3,163 | -9,478 | -3,251 | 2,854 |
| Beginning Cash Position | 254,222 | 208,784 | 552,827 | 396,097 | 268,670 |
| End Cash Position | 308,566 | 254,222 | 208,784 | 552,827 | 396,097 |
| Net Cash Flow | $54,344 | $45,438 | $-344,043 | $156,730 | $127,427 |
| Free Cash Flow | |||||
| Operating Cash Flow | 204,033 | 166,201 | -62,129 | 267,538 | 222,752 |
| Capital Expenditure | -79,373 | -83,893 | -90,311 | -68,542 | -92,005 |
| Free Cash Flow | 124,660 | 82,308 | -152,440 | 198,996 | 130,747 |